Global Blood-Brain Barrier Transport Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Blood-Brain Barrier Transport Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Blood-Brain Barrier Transport Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Blood-Brain Barrier Transport Drugs by Country/Region, 2017, 2022 & 2028

2.2 Blood-Brain Barrier Transport Drugs Segment by Type

2.2.1 Carrier-mediated Transport

2.2.2 Receptor-mediated Transport

2.2.3 Absorptive-mediated Transport

2.2.4 Active Efflux Transport

2.2.5 Others

2.3 Blood-Brain Barrier Transport Drugs Sales by Type

2.3.1 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Blood-Brain Barrier Transport Drugs Sale Price by Type (2017-2022)

2.4 Blood-Brain Barrier Transport Drugs Segment by Application

2.4.1 Alzheimer's Disease

2.4.2 Epilepsy

2.4.3 Parkinson's Disease

2.4.4 Multiple Sclerosis

2.4.5 Hunter's Syndrome

2.4.6 Brain Cancer

2.4.7 Others

2.5 Blood-Brain Barrier Transport Drugs Sales by Application

2.5.1 Global Blood-Brain Barrier Transport Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Blood-Brain Barrier Transport Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Blood-Brain Barrier Transport Drugs Sale Price by Application (2017-2022)

3 Global Blood-Brain Barrier Transport Drugs by Company

3.1 Global Blood-Brain Barrier Transport Drugs Breakdown Data by Company

3.1.1 Global Blood-Brain Barrier Transport Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2020-2022)

3.2 Global Blood-Brain Barrier Transport Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Blood-Brain Barrier Transport Drugs Revenue by Company (2020-2022)

3.2.2 Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Blood-Brain Barrier Transport Drugs Sale Price by Company

3.4 Key Manufacturers Blood-Brain Barrier Transport Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Blood-Brain Barrier Transport Drugs Product Location Distribution

3.4.2 Players Blood-Brain Barrier Transport Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Blood-Brain Barrier Transport Drugs by Geographic Region

4.1 World Historic Blood-Brain Barrier Transport Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Blood-Brain Barrier Transport Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Blood-Brain Barrier Transport Drugs Annual Revenue by Geographic Region

4.2 World Historic Blood-Brain Barrier Transport Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Blood-Brain Barrier Transport Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Blood-Brain Barrier Transport Drugs Annual Revenue by Country/Region

4.3 Americas Blood-Brain Barrier Transport Drugs Sales Growth

4.4 APAC Blood-Brain Barrier Transport Drugs Sales Growth

4.5 Europe Blood-Brain Barrier Transport Drugs Sales Growth

4.6 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Growth

5 Americas

5.1 Americas Blood-Brain Barrier Transport Drugs Sales by Country

5.1.1 Americas Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022)

5.1.2 Americas Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022)

5.2 Americas Blood-Brain Barrier Transport Drugs Sales by Type

5.3 Americas Blood-Brain Barrier Transport Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Blood-Brain Barrier Transport Drugs Sales by Region

6.1.1 APAC Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022)

6.1.2 APAC Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022)

6.2 APAC Blood-Brain Barrier Transport Drugs Sales by Type

6.3 APAC Blood-Brain Barrier Transport Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Blood-Brain Barrier Transport Drugs by Country

7.1.1 Europe Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022)

7.1.2 Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022)

7.2 Europe Blood-Brain Barrier Transport Drugs Sales by Type

7.3 Europe Blood-Brain Barrier Transport Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Blood-Brain Barrier Transport Drugs by Country

8.1.1 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Type

8.3 Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs

10.3 Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs

10.4 Industry Chain Structure of Blood-Brain Barrier Transport Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Blood-Brain Barrier Transport Drugs Distributors

11.3 Blood-Brain Barrier Transport Drugs Customer

12 World Forecast Review for Blood-Brain Barrier Transport Drugs by Geographic Region

12.1 Global Blood-Brain Barrier Transport Drugs Market Size Forecast by Region

12.1.1 Global Blood-Brain Barrier Transport Drugs Forecast by Region (2023-2028)

12.1.2 Global Blood-Brain Barrier Transport Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Blood-Brain Barrier Transport Drugs Forecast by Type

12.7 Global Blood-Brain Barrier Transport Drugs Forecast by Application

13 Key Players Analysis

13.1 Cyclenium

13.1.1 Cyclenium Company Information

13.1.2 Cyclenium Blood-Brain Barrier Transport Drugs Product Offered

13.1.3 Cyclenium Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Cyclenium Main Business Overview

13.1.5 Cyclenium Latest Developments

13.2 BioAdvance

13.2.1 BioAdvance Company Information

13.2.2 BioAdvance Blood-Brain Barrier Transport Drugs Product Offered

13.2.3 BioAdvance Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 BioAdvance Main Business Overview

13.2.5 BioAdvance Latest Developments

13.3 EIP Pharma

13.3.1 EIP Pharma Company Information

13.3.2 EIP Pharma Blood-Brain Barrier Transport Drugs Product Offered

13.3.3 EIP Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 EIP Pharma Main Business Overview

13.3.5 EIP Pharma Latest Developments

13.4 Bioasis

13.4.1 Bioasis Company Information

13.4.2 Bioasis Blood-Brain Barrier Transport Drugs Product Offered

13.4.3 Bioasis Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bioasis Main Business Overview

13.4.5 Bioasis Latest Developments

13.5 Immune Pharmaceuticals

13.5.1 Immune Pharmaceuticals Company Information

13.5.2 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product Offered

13.5.3 Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Immune Pharmaceuticals Main Business Overview

13.5.5 Immune Pharmaceuticals Latest Developments

13.6 AZ Therapies

13.6.1 AZ Therapies Company Information

13.6.2 AZ Therapies Blood-Brain Barrier Transport Drugs Product Offered

13.6.3 AZ Therapies Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 AZ Therapies Main Business Overview

13.6.5 AZ Therapies Latest Developments

13.7 Palobiofarma

13.7.1 Palobiofarma Company Information

13.7.2 Palobiofarma Blood-Brain Barrier Transport Drugs Product Offered

13.7.3 Palobiofarma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Palobiofarma Main Business Overview

13.7.5 Palobiofarma Latest Developments

13.8 Bach Pharma

13.8.1 Bach Pharma Company Information

13.8.2 Bach Pharma Blood-Brain Barrier Transport Drugs Product Offered

13.8.3 Bach Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bach Pharma Main Business Overview

13.8.5 Bach Pharma Latest Developments

13.9 BrainsGate

13.9.1 BrainsGate Company Information

13.9.2 BrainsGate Blood-Brain Barrier Transport Drugs Product Offered

13.9.3 BrainsGate Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 BrainsGate Main Business Overview

13.9.5 BrainsGate Latest Developments

13.10 CarThera

13.10.1 CarThera Company Information

13.10.2 CarThera Blood-Brain Barrier Transport Drugs Product Offered

13.10.3 CarThera Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 CarThera Main Business Overview

13.10.5 CarThera Latest Developments

13.11 Dainippon Sumitomo Pharma

13.11.1 Dainippon Sumitomo Pharma Company Information

13.11.2 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product Offered

13.11.3 Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Dainippon Sumitomo Pharma Main Business Overview

13.11.5 Dainippon Sumitomo Pharma Latest Developments

13.12 Fluorinov Pharma

13.12.1 Fluorinov Pharma Company Information

13.12.2 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product Offered

13.12.3 Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Fluorinov Pharma Main Business Overview

13.12.5 Fluorinov Pharma Latest Developments

13.13 Fondazione Telethon

13.13.1 Fondazione Telethon Company Information

13.13.2 Fondazione Telethon Blood-Brain Barrier Transport Drugs Product Offered

13.13.3 Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Fondazione Telethon Main Business Overview

13.13.5 Fondazione Telethon Latest Developments

13.14 Minoryx

13.14.1 Minoryx Company Information

13.14.2 Minoryx Blood-Brain Barrier Transport Drugs Product Offered

13.14.3 Minoryx Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Minoryx Main Business Overview

13.14.5 Minoryx Latest Developments

13.15 NewGen Therapeutics

13.15.1 NewGen Therapeutics Company Information

13.15.2 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product Offered

13.15.3 NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 NewGen Therapeutics Main Business Overview

13.15.5 NewGen Therapeutics Latest Developments

14 Research Findings and Conclusion

Table 1. Blood-Brain Barrier Transport Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Blood-Brain Barrier Transport Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Carrier-mediated Transport

Table 4. Major Players of Receptor-mediated Transport

Table 5. Major Players of Absorptive-mediated Transport

Table 6. Major Players of Active Efflux Transport

Table 7. Major Players of Others

Table 8. Global Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

Table 10. Global Blood-Brain Barrier Transport Drugs Revenue by Type (2017-2022) & ($ million)

Table 11. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2017-2022)

Table 12. Global Blood-Brain Barrier Transport Drugs Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Table 15. Global Blood-Brain Barrier Transport Drugs Revenue by Application (2017-2022)

Table 16. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application (2017-2022)

Table 17. Global Blood-Brain Barrier Transport Drugs Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Blood-Brain Barrier Transport Drugs Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Company (2020-2022)

Table 20. Global Blood-Brain Barrier Transport Drugs Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Company (2020-2022)

Table 22. Global Blood-Brain Barrier Transport Drugs Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Blood-Brain Barrier Transport Drugs Producing Area Distribution and Sales Area

Table 24. Players Blood-Brain Barrier Transport Drugs Products Offered

Table 25. Blood-Brain Barrier Transport Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Blood-Brain Barrier Transport Drugs Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Blood-Brain Barrier Transport Drugs Sales Market Share Geographic Region (2017-2022)

Table 30. Global Blood-Brain Barrier Transport Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Blood-Brain Barrier Transport Drugs Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Country/Region (2017-2022)

Table 34. Global Blood-Brain Barrier Transport Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2022)

Table 38. Americas Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2022)

Table 40. Americas Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

Table 42. Americas Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Table 44. APAC Blood-Brain Barrier Transport Drugs Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2022)

Table 46. APAC Blood-Brain Barrier Transport Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Blood-Brain Barrier Transport Drugs Revenue Market Share by Region (2017-2022)

Table 48. APAC Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

Table 50. APAC Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Table 52. Europe Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2022)

Table 54. Europe Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2022)

Table 56. Europe Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

Table 58. Europe Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Blood-Brain Barrier Transport Drugs

Table 69. Key Market Challenges & Risks of Blood-Brain Barrier Transport Drugs

Table 70. Key Industry Trends of Blood-Brain Barrier Transport Drugs

Table 71. Blood-Brain Barrier Transport Drugs Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Blood-Brain Barrier Transport Drugs Distributors List

Table 74. Blood-Brain Barrier Transport Drugs Customer List

Table 75. Global Blood-Brain Barrier Transport Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Blood-Brain Barrier Transport Drugs Sales Market Forecast by Region

Table 77. Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Blood-Brain Barrier Transport Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Blood-Brain Barrier Transport Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Blood-Brain Barrier Transport Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Blood-Brain Barrier Transport Drugs Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Blood-Brain Barrier Transport Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Blood-Brain Barrier Transport Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Blood-Brain Barrier Transport Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Blood-Brain Barrier Transport Drugs Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Blood-Brain Barrier Transport Drugs Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Blood-Brain Barrier Transport Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Blood-Brain Barrier Transport Drugs Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Blood-Brain Barrier Transport Drugs Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Blood-Brain Barrier Transport Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Blood-Brain Barrier Transport Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 95. Cyclenium Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 96. Cyclenium Blood-Brain Barrier Transport Drugs Product Offered

Table 97. Cyclenium Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Cyclenium Main Business

Table 99. Cyclenium Latest Developments

Table 100. BioAdvance Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 101. BioAdvance Blood-Brain Barrier Transport Drugs Product Offered

Table 102. BioAdvance Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. BioAdvance Main Business

Table 104. BioAdvance Latest Developments

Table 105. EIP Pharma Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 106. EIP Pharma Blood-Brain Barrier Transport Drugs Product Offered

Table 107. EIP Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. EIP Pharma Main Business

Table 109. EIP Pharma Latest Developments

Table 110. Bioasis Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 111. Bioasis Blood-Brain Barrier Transport Drugs Product Offered

Table 112. Bioasis Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Bioasis Main Business

Table 114. Bioasis Latest Developments

Table 115. Immune Pharmaceuticals Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 116. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Product Offered

Table 117. Immune Pharmaceuticals Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Immune Pharmaceuticals Main Business

Table 119. Immune Pharmaceuticals Latest Developments

Table 120. AZ Therapies Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 121. AZ Therapies Blood-Brain Barrier Transport Drugs Product Offered

Table 122. AZ Therapies Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. AZ Therapies Main Business

Table 124. AZ Therapies Latest Developments

Table 125. Palobiofarma Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 126. Palobiofarma Blood-Brain Barrier Transport Drugs Product Offered

Table 127. Palobiofarma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Palobiofarma Main Business

Table 129. Palobiofarma Latest Developments

Table 130. Bach Pharma Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 131. Bach Pharma Blood-Brain Barrier Transport Drugs Product Offered

Table 132. Bach Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Bach Pharma Main Business

Table 134. Bach Pharma Latest Developments

Table 135. BrainsGate Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 136. BrainsGate Blood-Brain Barrier Transport Drugs Product Offered

Table 137. BrainsGate Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. BrainsGate Main Business

Table 139. BrainsGate Latest Developments

Table 140. CarThera Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 141. CarThera Blood-Brain Barrier Transport Drugs Product Offered

Table 142. CarThera Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. CarThera Main Business

Table 144. CarThera Latest Developments

Table 145. Dainippon Sumitomo Pharma Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 146. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Product Offered

Table 147. Dainippon Sumitomo Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Dainippon Sumitomo Pharma Main Business

Table 149. Dainippon Sumitomo Pharma Latest Developments

Table 150. Fluorinov Pharma Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 151. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Product Offered

Table 152. Fluorinov Pharma Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Fluorinov Pharma Main Business

Table 154. Fluorinov Pharma Latest Developments

Table 155. Fondazione Telethon Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 156. Fondazione Telethon Blood-Brain Barrier Transport Drugs Product Offered

Table 157. Fondazione Telethon Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 158. Fondazione Telethon Main Business

Table 159. Fondazione Telethon Latest Developments

Table 160. Minoryx Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 161. Minoryx Blood-Brain Barrier Transport Drugs Product Offered

Table 162. Minoryx Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 163. Minoryx Main Business

Table 164. Minoryx Latest Developments

Table 165. NewGen Therapeutics Basic Information, Blood-Brain Barrier Transport Drugs Manufacturing Base, Sales Area and Its Competitors

Table 166. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Product Offered

Table 167. NewGen Therapeutics Blood-Brain Barrier Transport Drugs Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 168. NewGen Therapeutics Main Business

Table 169. NewGen Therapeutics Latest Developments

List of Figures

Figure 1. Picture of Blood-Brain Barrier Transport Drugs

Figure 2. Blood-Brain Barrier Transport Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Blood-Brain Barrier Transport Drugs Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Blood-Brain Barrier Transport Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Blood-Brain Barrier Transport Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Carrier-mediated Transport

Figure 10. Product Picture of Receptor-mediated Transport

Figure 11. Product Picture of Absorptive-mediated Transport

Figure 12. Product Picture of Active Efflux Transport

Figure 13. Product Picture of Others

Figure 14. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Type in 2021

Figure 15. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Type (2017-2022)

Figure 16. Blood-Brain Barrier Transport Drugs Consumed in Alzheimer's Disease

Figure 17. Global Blood-Brain Barrier Transport Drugs Market: Alzheimer's Disease (2017-2022) & (K Pcs)

Figure 18. Blood-Brain Barrier Transport Drugs Consumed in Epilepsy

Figure 19. Global Blood-Brain Barrier Transport Drugs Market: Epilepsy (2017-2022) & (K Pcs)

Figure 20. Blood-Brain Barrier Transport Drugs Consumed in Parkinson's Disease

Figure 21. Global Blood-Brain Barrier Transport Drugs Market: Parkinson's Disease (2017-2022) & (K Pcs)

Figure 22. Blood-Brain Barrier Transport Drugs Consumed in Multiple Sclerosis

Figure 23. Global Blood-Brain Barrier Transport Drugs Market: Multiple Sclerosis (2017-2022) & (K Pcs)

Figure 24. Blood-Brain Barrier Transport Drugs Consumed in Hunter's Syndrome

Figure 25. Global Blood-Brain Barrier Transport Drugs Market: Hunter's Syndrome (2017-2022) & (K Pcs)

Figure 26. Blood-Brain Barrier Transport Drugs Consumed in Brain Cancer

Figure 27. Global Blood-Brain Barrier Transport Drugs Market: Brain Cancer (2017-2022) & (K Pcs)

Figure 28. Blood-Brain Barrier Transport Drugs Consumed in Others

Figure 29. Global Blood-Brain Barrier Transport Drugs Market: Others (2017-2022) & (K Pcs)

Figure 30. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Application (2017-2022)

Figure 31. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Application in 2021

Figure 32. Blood-Brain Barrier Transport Drugs Revenue Market by Company in 2021 ($ Million)

Figure 33. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Company in 2021

Figure 34. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 35. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Geographic Region in 2021

Figure 36. Global Blood-Brain Barrier Transport Drugs Sales Market Share by Region (2017-2022)

Figure 37. Global Blood-Brain Barrier Transport Drugs Revenue Market Share by Country/Region in 2021

Figure 38. Americas Blood-Brain Barrier Transport Drugs Sales 2017-2022 (K Pcs)

Figure 39. Americas Blood-Brain Barrier Transport Drugs Revenue 2017-2022 ($ Millions)

Figure 40. APAC Blood-Brain Barrier Transport Drugs Sales 2017-2022 (K Pcs)

Figure 41. APAC Blood-Brain Barrier Transport Drugs Revenue 2017-2022 ($ Millions)

Figure 42. Europe Blood-Brain Barrier Transport Drugs Sales 2017-2022 (K Pcs)

Figure 43. Europe Blood-Brain Barrier Transport Drugs Revenue 2017-2022 ($ Millions)

Figure 44. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales 2017-2022 (K Pcs)

Figure 45. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue 2017-2022 ($ Millions)

Figure 46. Americas Blood-Brain Barrier Transport Drugs Sales Market Share by Country in 2021

Figure 47. Americas Blood-Brain Barrier Transport Drugs Revenue Market Share by Country in 2021

Figure 48. United States Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. Canada Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Mexico Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. Brazil Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. APAC Blood-Brain Barrier Transport Drugs Sales Market Share by Region in 2021

Figure 53. APAC Blood-Brain Barrier Transport Drugs Revenue Market Share by Regions in 2021

Figure 54. China Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 55. Japan Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. South Korea Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. Southeast Asia Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. India Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Australia Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Europe Blood-Brain Barrier Transport Drugs Sales Market Share by Country in 2021

Figure 61. Europe Blood-Brain Barrier Transport Drugs Revenue Market Share by Country in 2021

Figure 62. Germany Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. France Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. UK Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Italy Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. Russia Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Middle East & Africa Blood-Brain Barrier Transport Drugs Sales Market Share by Country in 2021

Figure 68. Middle East & Africa Blood-Brain Barrier Transport Drugs Revenue Market Share by Country in 2021

Figure 69. Egypt Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 70. South Africa Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 71. Israel Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 72. Turkey Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 73. GCC Country Blood-Brain Barrier Transport Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 74. Manufacturing Cost Structure Analysis of Blood-Brain Barrier Transport Drugs in 2021

Figure 75. Manufacturing Process Analysis of Blood-Brain Barrier Transport Drugs

Figure 76. Industry Chain Structure of Blood-Brain Barrier Transport Drugs

Figure 77. Channels of Distribution

Figure 78. Distributors Profiles